CIK 0001849296
- Non-accelerated filer
- Emerging growth company
OKYO Pharma Ltd
Sign in to watch- Ticker
- OKYO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Entity type
- Other
- Phone
- +44 2074952379
- Business address
- 55 PARK LANE, LONDON, United Kingdom, W1K 1NA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-23 | CERRONE GABRIELE M Executive Chairman | Other acquisition | +499,468 | $1.50 | $749K | 9,107,832 |
| 2023-09-15 | BRANCACCIO JOHN P Director | Purchase | +16,670 | $1.50 | $25K | 16,670 |
| 2022-05-19 | CERRONE GABRIELE M Executive Chairman | Purchase | +5,800,000 | $0.08 | $441K | 548,981,215 |
| 2022-05-19 | JACOB GARY S Chief Executive Officer | Purchase | +12,500 | $4.00 | $50K | 12,500 |
| 2022-05-19 | CERRONE GABRIELE M Non-Executive Chairman | Purchase | +37,500 | $4.00 | $150K | 62,500 |
| 2022-05-17 | CERRONE GABRIELE M Non-Executive Chairman | Purchase | +25,000 | $3.87 | $97K | 25,000 |
| 2022-05-17 | CERRONE GABRIELE M Non-Executive Chairman | Purchase | +1,625,000 | $0.06 | $97K | 544,806,215 |
Page 2 of 2 · 27 trades